Cargando…

Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study

BACKGROUND: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients. OBJECTIVE: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact. METHODS: Lung cancer patients currently or recently treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Groen, Wim G, Kuijpers, Wilma, Oldenburg, Hester SA, Wouters, Michel WJM, Aaronson, Neil K, van Harten, Wim H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566630/
https://www.ncbi.nlm.nih.gov/pubmed/28790025
http://dx.doi.org/10.2196/cancer.7443
_version_ 1783258584107188224
author Groen, Wim G
Kuijpers, Wilma
Oldenburg, Hester SA
Wouters, Michel WJM
Aaronson, Neil K
van Harten, Wim H
author_facet Groen, Wim G
Kuijpers, Wilma
Oldenburg, Hester SA
Wouters, Michel WJM
Aaronson, Neil K
van Harten, Wim H
author_sort Groen, Wim G
collection PubMed
description BACKGROUND: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients. OBJECTIVE: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact. METHODS: Lung cancer patients currently or recently treated with curative intent could use MyAVL noncommittally for 4 months. Feasibility, usability, and preliminary impact (ie, patient activation, quality of life, and physical activity) were studied by means of questionnaires, a focus group, and analysis of user log data. RESULTS: We included 37 of 123 eligible patients (mean age 59.6 years). The majority of responses (82%) were positive about using MyAVL, 69% saw it as a valuable addition to care, and 56% perceived increased control over their health. No positive effects could be substantiated on the impact measures. CONCLUSIONS: MyAVL appears to be a feasible and user-friendly, multifunctional eHealth program for a selected group of lung cancer patients. However, it needs further improvements to positively impact patient outcomes.
format Online
Article
Text
id pubmed-5566630
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-55666302017-09-07 Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study Groen, Wim G Kuijpers, Wilma Oldenburg, Hester SA Wouters, Michel WJM Aaronson, Neil K van Harten, Wim H JMIR Cancer Original Paper BACKGROUND: MyAVL is an interactive portal for cancer patients that aims to support lung cancer patients. OBJECTIVE: We aimed to evaluate the feasibility and usability of the patient portal and generate preliminary evidence on its impact. METHODS: Lung cancer patients currently or recently treated with curative intent could use MyAVL noncommittally for 4 months. Feasibility, usability, and preliminary impact (ie, patient activation, quality of life, and physical activity) were studied by means of questionnaires, a focus group, and analysis of user log data. RESULTS: We included 37 of 123 eligible patients (mean age 59.6 years). The majority of responses (82%) were positive about using MyAVL, 69% saw it as a valuable addition to care, and 56% perceived increased control over their health. No positive effects could be substantiated on the impact measures. CONCLUSIONS: MyAVL appears to be a feasible and user-friendly, multifunctional eHealth program for a selected group of lung cancer patients. However, it needs further improvements to positively impact patient outcomes. JMIR Publications 2017-08-08 /pmc/articles/PMC5566630/ /pubmed/28790025 http://dx.doi.org/10.2196/cancer.7443 Text en ©Wim G Groen, Wilma Kuijpers, Hester SA Oldenburg, Michel WJM Wouters, Neil K Aaronson, Wim H van Harten. Originally published in JMIR Cancer (http://cancer.jmir.org), 08.08.2017. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Groen, Wim G
Kuijpers, Wilma
Oldenburg, Hester SA
Wouters, Michel WJM
Aaronson, Neil K
van Harten, Wim H
Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
title Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
title_full Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
title_fullStr Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
title_full_unstemmed Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
title_short Supporting Lung Cancer Patients With an Interactive Patient Portal: Feasibility Study
title_sort supporting lung cancer patients with an interactive patient portal: feasibility study
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566630/
https://www.ncbi.nlm.nih.gov/pubmed/28790025
http://dx.doi.org/10.2196/cancer.7443
work_keys_str_mv AT groenwimg supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy
AT kuijperswilma supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy
AT oldenburghestersa supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy
AT woutersmichelwjm supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy
AT aaronsonneilk supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy
AT vanhartenwimh supportinglungcancerpatientswithaninteractivepatientportalfeasibilitystudy